Fractyl Health (GUTS) Competitors $0.97 -0.02 (-1.90%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$0.99 +0.02 (+2.35%) As of 08/29/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock GUTS vs. CVRX, KRMD, INFU, SI, CV, MBOT, ELMD, BSGM, LNSR, and PDEXShould you be buying Fractyl Health stock or one of its competitors? The main competitors of Fractyl Health include CVRx (CVRX), KORU Medical Systems (KRMD), InfuSystem (INFU), Shoulder Innovations (SI), CapsoVision (CV), Microbot Medical (MBOT), Electromed (ELMD), Biosig Technologies (BSGM), LENSAR (LNSR), and Pro-Dex (PDEX). These companies are all part of the "medical equipment" industry. Fractyl Health vs. Its Competitors CVRx KORU Medical Systems InfuSystem Shoulder Innovations CapsoVision Microbot Medical Electromed Biosig Technologies LENSAR Pro-Dex Fractyl Health (NASDAQ:GUTS) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends. Is GUTS or CVRX more profitable? CVRx has a net margin of -95.61% compared to Fractyl Health's net margin of -73,864.52%. CVRx's return on equity of -79.31% beat Fractyl Health's return on equity.Company Net Margins Return on Equity Return on Assets Fractyl Health-73,864.52% -584.35% -102.88% CVRx -95.61%-79.31%-40.96% Which has more volatility and risk, GUTS or CVRX? Fractyl Health has a beta of 1.66, meaning that its share price is 66% more volatile than the S&P 500. Comparatively, CVRx has a beta of 1.27, meaning that its share price is 27% more volatile than the S&P 500. Do insiders and institutionals have more ownership in GUTS or CVRX? 75.3% of CVRx shares are held by institutional investors. 27.0% of Fractyl Health shares are held by company insiders. Comparatively, 13.9% of CVRx shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has better earnings & valuation, GUTS or CVRX? CVRx has higher revenue and earnings than Fractyl Health. CVRx is trading at a lower price-to-earnings ratio than Fractyl Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFractyl Health$90K542.68-$68.69M-$2.06-0.47CVRx$54.65M3.76-$59.97M-$2.10-3.74 Do analysts recommend GUTS or CVRX? Fractyl Health currently has a consensus target price of $6.53, indicating a potential upside of 572.71%. CVRx has a consensus target price of $14.00, indicating a potential upside of 78.34%. Given Fractyl Health's stronger consensus rating and higher probable upside, research analysts plainly believe Fractyl Health is more favorable than CVRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fractyl Health 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00CVRx 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.86 Does the media favor GUTS or CVRX? In the previous week, Fractyl Health had 3 more articles in the media than CVRx. MarketBeat recorded 4 mentions for Fractyl Health and 1 mentions for CVRx. CVRx's average media sentiment score of 1.87 beat Fractyl Health's score of 1.15 indicating that CVRx is being referred to more favorably in the news media. Company Overall Sentiment Fractyl Health Positive CVRx Very Positive SummaryCVRx beats Fractyl Health on 9 of the 17 factors compared between the two stocks. Get Fractyl Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GUTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GUTS vs. The Competition Export to ExcelMetricFractyl HealthMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$49.79M$2.49B$5.66B$9.84BDividend YieldN/A1.67%3.93%4.04%P/E Ratio-0.4722.8083.2726.61Price / Sales542.68509.21451.26176.28Price / CashN/A177.7737.7059.65Price / Book-2.705.9810.556.59Net Income-$68.69M$32.94M$3.27B$266.12M7 Day Performance-4.78%-1.28%0.42%0.17%1 Month Performance-46.64%3.54%5.91%3.02%1 Year Performance-72.25%-3.68%48.11%19.69% Fractyl Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GUTSFractyl Health2.3048 of 5 stars$0.97-1.9%$6.53+572.7%-72.9%$49.79M$90K-0.47102Positive NewsAnalyst ForecastCVRXCVRx2.5041 of 5 stars$7.45-4.5%$14.00+87.9%-20.4%$203.98M$51.29M-3.55160Positive NewsKRMDKORU Medical Systems1.0997 of 5 stars$4.20-4.1%$4.63+10.1%+73.0%$202.51M$33.65M-46.6780News CoveragePositive NewsINFUInfuSystem2.6802 of 5 stars$9.87+3.1%$12.50+26.6%+66.6%$195.48M$139.89M164.53410SIShoulder Innovations3.2964 of 5 stars$15.01+18.1%$20.00+33.2%N/A$193.55MN/A-0.5061Analyst UpgradeCVCapsoVisionN/A$3.99-0.3%$5.50+37.8%N/A$187.10MN/A0.0090MBOTMicrobot Medical1.3307 of 5 stars$4.16+8.1%$9.00+116.3%+314.1%$175.35MN/A-7.1720Analyst DowngradeGap UpHigh Trading VolumeELMDElectromed3.1658 of 5 stars$20.20-0.3%$33.50+65.8%+55.3%$169.40M$61.44M26.93160Trending NewsAnalyst ForecastAnalyst RevisionBSGMBiosig Technologies2.2382 of 5 stars$5.30+2.3%$10.00+88.7%+976.6%$162.75M$40K0.0050Gap UpLNSRLENSAR1.0211 of 5 stars$12.66-1.9%$15.00+18.5%+164.1%$153.96M$53.49M-3.01110Positive NewsPDEXPro-Dex1.8549 of 5 stars$46.21+0.4%$56.00+21.2%+99.6%$150.09M$53.84M16.50140News CoverageUpcoming Earnings Related Companies and Tools Related Companies CVRx Alternatives KORU Medical Systems Alternatives InfuSystem Alternatives Shoulder Innovations Alternatives CapsoVision Alternatives Microbot Medical Alternatives Electromed Alternatives Biosig Technologies Alternatives LENSAR Alternatives Pro-Dex Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GUTS) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fractyl Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fractyl Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GUTS Stock Alerts